| 发明名称 |
Cancer Drug and Uses |
| 摘要 |
A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual. |
| 申请公布号 |
US2014199296(A1) |
申请公布日期 |
2014.07.17 |
| 申请号 |
US201414155320 |
申请日期 |
2014.01.14 |
| 申请人 |
Biocopea Limited |
发明人 |
Bannister Robin M.;Brew John;Stoloff Gregory A. |
| 分类号 |
A61K9/48;A61K31/7068;A61K31/517;A61K39/395;A61K31/155;A23L1/30;A61K31/4184;A61K31/366;A61K31/225;A61K31/19;A61K31/05;A61K31/353;A61K31/357;A61K31/40 |
主分类号 |
A61K9/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition comprising one or more cancer therapeutics. |
| 地址 |
London GB |
